Brief: Athersys Inc Announces Restructuring, Management Changes To Focus On Existing Clinical Programs

Athersys

02/06/2022 21:10

June 2 (Reuters) - Athersys Inc  ATHX.O :
    * ATHERSYS ANNOUNCES RESTRUCTURING AND MANAGEMENT CHANGES TO
FOCUS
ON ITS EXISTING CLINICAL PROGRAMS
    * ATHERSYS INC - REDUCING ITS WORKFORCE UP TO 70%, WITH
MAJORITY
OF REDUCTION EXPECTED TO BE COMPLETED BY END OF JUNE 2022
    * ATHERSYS INC - AS PART OF RESTRUCTURING PLAN, COMPANY ALSO
ANNOUNCED CHANGES TO ITS EXECUTIVE TEAM
    * ATHERSYS INC - WILLIAM LEHMANN, PRESIDENT AND CHIEF
OPERATING
OFFICER, LEFT COMPANY ON MAY 31, 2022
    * ATHERSYS INC - JOHN HARRINGTON, EXECUTIVE VICE PRESIDENT,
CHIEF
SCIENTIFIC OFFICER AND  IVOR MACLEOD, CFO, WILL BE LEAVING
COMPANY ON JUNE 30, 2022
    * ATHERSYS - EVEN WITH REDUCED COSTS FROM RESTRUCTURING,
NEED TO
RAISE ADDITIONAL CAPITAL TO REACH FULL ENROLLMENT, DATA READOUT
FROM MASTERS-2 TRIAL
    * ATHERSYS INC - WILL CONTINUE TO PARTNER WITH HEALIOS K.K.
IN
JAPAN TO ADVANCE ISCHEMIC STROKE AND ACUTE RESPIRATORY DISTRESS
SYNDROME (ARDS) PROGRAMS

Source text for Eikon:  ID:nBw8VLvs2a 
Further company coverage:  ATHX.O